Global Serological Transplant Diagnostics Market 2017-2021
About Serological Transplant Diagnostics
Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology. Donor and recipient cells, tissues, and organs should match or be compatible with the recipient's or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not accept. This can lead to the chronic rejection of organs.
Technavio’s analysts forecast the global serological transplant diagnostics market to grow at a CAGR of 4.43% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global serological transplant diagnostics market for 2017-2021. To calculate the market size, the report considers sales, volume, and value of serological transplant diagnostics products.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Serological Transplant Diagnostics Market 2017-2021
Technavio recognizes the following companies as the key players in the global serological transplant diagnostics market: Bio-Rad Laboratories, Immucor, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Agena Bioscience, AVIOQ, BAG Healthcare, BD, Beckman Coulter, Biocell Medicare, Biogenuix, DIAGAST, Grifols, Hemo bioscience, Institut de Biotechnologies, Lorne Laboratories, MTC INVITRO, Quotient Biodiagnostics, Reagent Kft, and Tulip Group.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is government initiatives for transplant research programs. Governments worldwide have undertaken initiatives to reduce the waiting time for people seeking organ donors. They have provided funding to develop artificial organs and conduct R&D on transplants.”
According to the report, one driver in the market is advancements in technology for organ transplantation. The development of new and improved transplantation products such as tissue products, tissue typing technology, and surgical medical instruments drives the growth of the market. Advances in organ preservation have increased the efficiency of organs, which has led to a decrease in waiting time. In addition, vendors offer better and more efficient immunosuppressant drugs for transplant procedures.
Further, the report states that one challenge in the market is high cost of transplant and unfavorable reimbursement scenario. Expenses related to transplantation include the cost of organ, transplantation procedure cost, and transplant diagnostic cost. The high cost often discourages patients from opting for these procedures. Also, the diagnostic cost is hindering laboratories and hospitals from adopting high-cost sequencers. Further, the cost of the procedure and medication can lead to out-of-pocket expense, which is hindering the growth of the global serological transplant diagnostics market.
Bio-Rad Laboratories, Immucor, Siemens Healthineers, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Agena Bioscience, AVIOQ, BAG Healthcare, BD, Beckman Coulter, Biocell Medicare, Biogenuix, DIAGAST, Grifols, Hemo bioscience, Institut de Biotechnologies, Lorne Laboratories, MTC INVITRO, Quotient Biodiagnostics, Reagent Kft, and Tulip Group.